← Evidence map

ReviewPain and therapy2020

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine.

Ivan Urits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32222952